JPS61277609A - Bathing agent - Google Patents
Bathing agentInfo
- Publication number
- JPS61277609A JPS61277609A JP11953085A JP11953085A JPS61277609A JP S61277609 A JPS61277609 A JP S61277609A JP 11953085 A JP11953085 A JP 11953085A JP 11953085 A JP11953085 A JP 11953085A JP S61277609 A JPS61277609 A JP S61277609A
- Authority
- JP
- Japan
- Prior art keywords
- derivative
- tocopherol
- bath
- nonionic
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000003287 bathing Methods 0.000 title abstract description 9
- 239000011732 tocopherol Substances 0.000 claims abstract description 19
- 229930003799 tocopherol Natural products 0.000 claims abstract description 19
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229960001295 tocopherol Drugs 0.000 claims abstract description 17
- 235000010384 tocopherol Nutrition 0.000 claims abstract description 17
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims abstract description 17
- 229920013820 alkyl cellulose Polymers 0.000 claims abstract description 12
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims abstract description 5
- 239000000654 additive Substances 0.000 claims description 24
- 230000000996 additive effect Effects 0.000 claims description 13
- 239000002736 nonionic surfactant Substances 0.000 claims description 7
- 150000003611 tocopherol derivatives Chemical class 0.000 claims description 6
- 229940042585 tocopherol acetate Drugs 0.000 claims description 5
- 229920000609 methyl cellulose Polymers 0.000 claims description 4
- 239000001923 methylcellulose Substances 0.000 claims description 4
- -1 polyoxyethylene Polymers 0.000 abstract description 9
- 238000005187 foaming Methods 0.000 abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 6
- 238000002156 mixing Methods 0.000 abstract description 6
- 210000005259 peripheral blood Anatomy 0.000 abstract description 4
- 239000011886 peripheral blood Substances 0.000 abstract description 4
- 239000004094 surface-active agent Substances 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 abstract description 3
- 229920002678 cellulose Polymers 0.000 abstract description 3
- 239000001913 cellulose Substances 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 150000005215 alkyl ethers Chemical class 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 125000000129 anionic group Chemical group 0.000 abstract 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 abstract 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 description 6
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 5
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 5
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 5
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- 208000004044 Hypesthesia Diseases 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 235000019149 tocopherols Nutrition 0.000 description 2
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- IELOKBJPULMYRW-NJQVLOCASA-N D-alpha-Tocopheryl Acid Succinate Chemical compound OC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C IELOKBJPULMYRW-NJQVLOCASA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 230000037374 absorbed through the skin Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229940099418 d- alpha-tocopherol succinate Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、トコフェロールあるいはその誘導体を有効成
分とする入浴剤に関するものである。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a bath additive containing tocopherol or a derivative thereof as an active ingredient.
(従来の技術〕
入浴剤は入浴時浴槽に入れて、入浴剤に含有する成分を
浴湯中に溶出させ、その成分と入浴時の身体の状況と相
まって、身体を温めて血液の循環を良好にし、末梢血管
の血流を促進して新陳代謝を高めたり、又皮膚表面の角
質軟化作用により肌をなめらかにするなどの目的に用い
られるものである。(Conventional technology) Bath additives are placed in a bathtub when taking a bath, and the ingredients contained in the bath additives are eluted into the bath water.The ingredients combine with the physical condition of the body at the time of bathing to warm the body and improve blood circulation. It is used for the purpose of increasing metabolism by promoting blood flow in peripheral blood vessels, and smoothing the skin by keratin softening effect on the skin surface.
現在、このような入浴剤は、粉、顆粒、錠などの剤型で
、浴場に透明にとけるものが使用されている。そして、
この目的のための薬効成分として炭酸ナトリウム、塩化
ナトリウム、硫酸ナトリウムなどの無機塩類が賦形剤を
兼ねて主として使用されている。Currently, such bath additives are in the form of powder, granules, tablets, etc., and are transparent and dissolve in the bath. and,
Inorganic salts such as sodium carbonate, sodium chloride, and sodium sulfate are mainly used as medicinal ingredients for this purpose, and also serve as excipients.
上述の無機塩類を成分とする入浴剤は、無機塩類が水溶
性のために、皮脂になじまず皮膚への吸収が悪く、その
薬効が充分ではなかった。Bath additives containing the above-mentioned inorganic salts have insufficient medicinal efficacy because the inorganic salts are water-soluble and do not mix well with sebum and are poorly absorbed into the skin.
そこで、本発明者らは、トコフェロールあるいはその誘
導体が油性のため皮脂になじんで皮膚に吸収され易いこ
とに着目し、トコフェロールあるいはその誘導体を主成
分とする入浴剤の製法について検討した。しかしながら
、これらの化合物は油溶性の性質のため、これを浴場に
溶かすために加える界面活性剤により浴場表面に泡立を
生じ、更にトコフェロールあるいはその誘導体特有の湯
垢様浮遊物が生じ、入浴剤として著しくその商品価値を
減する難点があった。Therefore, the present inventors focused on the fact that tocopherol or a derivative thereof is oily and therefore easily absorbed into the skin by blending into sebum, and investigated a method for producing a bath additive containing tocopherol or a derivative thereof as a main component. However, because these compounds are oil-soluble, the surfactant added to dissolve them in the bath causes foaming on the bath surface, and also produces scale-like suspended matter peculiar to tocopherols or their derivatives, making them difficult to use as bath additives. There were drawbacks that significantly reduced its commercial value.
本発明はトコフェロールあるいはその誘導体の可溶化と
それに伴う泡立ち、ならびに湯垢様浮遊物の生成のない
トコフェロールあるいはその誘導体を含む入浴剤を得る
目的で鋭意研究の結果、非イオン界面活性剤と非イオン
系のアルキルセルロースあるいはその誘導体との組み合
わせによって、上述の難点が解消し、トコフェロールあ
るいはその誘導体の存する手足のしびれ、手足の冷えな
どの末梢血行障害による諸症状などの改善に寄与する効
果を入浴により身体に皮膚吸収により与える良好な入浴
剤を得ることを見出し本発明を完成した。The present invention was developed as a result of extensive research aimed at obtaining bath additives containing tocopherol or its derivatives that do not cause the solubilization of tocopherol or its derivatives, the resulting foaming, and the formation of scale-like floating substances. In combination with alkyl cellulose or its derivatives, the above-mentioned problems can be resolved, and the effect of tocopherol or its derivatives, which contributes to the improvement of various symptoms caused by peripheral blood circulation disorders such as numbness of the limbs and coldness of the hands and feet, can be achieved by bathing. The present invention has been completed based on the discovery that a good bath additive can be obtained through skin absorption.
本発明はトコフェロールあるいはその誘導体に非イオン
界面活性剤及び非イオン系のアルキルセルロース又はそ
の誘導体を配合してなる浴場に易溶性でしかも泡立ち及
び湯垢様浮遊物を生じない入浴剤である。The present invention is a bath additive which is easily soluble in baths and does not produce foaming or scale-like suspended matter, which is made by blending tocopherol or a derivative thereof with a nonionic surfactant and a nonionic alkyl cellulose or a derivative thereof.
本発明に使用するトコフェロールは一般にビタミンεと
称せられるもので、黄色〜黄褐色の透明で粘性のある油
状物質で、水には殆ど溶けない物質である。The tocopherol used in the present invention is generally referred to as vitamin ε, and is a transparent, viscous, oily substance with a yellow to tan color, and is almost insoluble in water.
また、トコフェロール誘導体は酢酸トコフェロール、コ
ハク酸トコフェロール等である。Further, tocopherol derivatives include tocopherol acetate, tocopherol succinate, and the like.
特に酢酸トコフェロールは無色〜黄色の透明で粘性のあ
る水に殆ど溶けない物質である。In particular, tocopherol acetate is a colorless to yellow, transparent, viscous substance that is almost insoluble in water.
本発明においては、トコフェロールもトコフェロール誘
導体も使用出来るが安定性の点で酢酸トコフェロールの
方が好ま、しい。In the present invention, both tocopherol and tocopherol derivatives can be used, but tocopherol acetate is preferred in terms of stability.
本発明に使用す−る非イオン界面活性剤としては、ポリ
オキシエチレンアルキルエーテルなどのエーテル型、ポ
リオキシエチレンソルビタン脂肪酸エステルなどのエー
テルエステル型及びポリオキシエチレン脂肪酸エステル
などのエステル型などの公知の非イオン界面活性剤があ
げられる。本発明においては、これら非イオン界面活性
剤は何れも使用できるが、HLB15以上好ましくは、
17〜18のものが、入浴剤組成中の添加量も少なくて
すみ好適である。The nonionic surfactants used in the present invention include known surfactants such as ether type such as polyoxyethylene alkyl ether, ether ester type such as polyoxyethylene sorbitan fatty acid ester, and ester type such as polyoxyethylene fatty acid ester. Examples include nonionic surfactants. In the present invention, any of these nonionic surfactants can be used, but HLB of 15 or more is preferable.
Those with numbers 17 to 18 are suitable because they can be added in small amounts in the bath additive composition.
本発明に使用する非イオン系アルキルセルロースあるい
はその誘導体としては、メチルセルロース、エチルセル
ロース等の様にセルロースの水酸基の一部がアルキルエ
ーテル化されたアルキルセルロース、または、この一部
アルキルエーテル化したアルキルセルロースのエーテル
化されていない残りの水酸基の一部を他の置換基例えば
ヒドロキシアルキル基で置換したヒドロキシプロピルメ
チルセルロースなどがあげられる。The nonionic alkylcellulose or its derivatives used in the present invention include alkylcellulose in which a portion of the hydroxyl groups of cellulose are alkyl etherified, such as methylcellulose and ethylcellulose, or alkylcellulose in which a portion of the hydroxyl groups of cellulose are alkyl etherified, such as methylcellulose and ethylcellulose. Examples include hydroxypropyl methyl cellulose in which a portion of the remaining hydroxyl groups that have not been etherified are substituted with other substituents, such as hydroxyalkyl groups.
本発明の入浴剤においては、前記トコフェロール、トコ
フェロール誘導体に対する非イオン界面活性剤及び非イ
オン系アルキルセルロース又はアルキルセルロース誘導
体の配合割合は製剤化の場合の他の成分により適宜変更
し得るが、大体それぞれ5〜0.2倍量(重り配合する
ことにより本発明の効果が十分に奏せられる。In the bath additive of the present invention, the blending ratio of the nonionic surfactant and the nonionic alkylcellulose or alkylcellulose derivative to the tocopherol or tocopherol derivative can be changed as appropriate depending on other ingredients in the formulation, but generally each 5 to 0.2 times the amount (the effects of the present invention can be fully exhibited by blending in a heavier amount).
本発明の入浴剤は上記トコフェロール、トコフェロール
誘導体、非イオン界面活性剤、非イオン系アルキルセル
ロースあるいはその誘導体0他に入浴剤として常用の成
分、例えば炭酸ナトリウム、塩化ナトリウム、硫酸ナト
リウム等の無機塩類、香料、色素などその使用場面に応
じて適宜配合する。The bath additives of the present invention include the above-mentioned tocopherols, tocopherol derivatives, nonionic surfactants, nonionic alkyl celluloses or their derivatives, and other ingredients commonly used as bath additives, such as inorganic salts such as sodium carbonate, sodium chloride, and sodium sulfate. Add fragrances, pigments, etc. as appropriate depending on the usage situation.
なお、本発明の入浴剤中のトコフェロール又はトコフェ
ロール誘導体の量は別に限定されるものではないが大体
0.4〜1%程度配合するのが好適である。The amount of tocopherol or tocopherol derivative in the bath additive of the present invention is not particularly limited, but it is preferably about 0.4 to 1%.
本発明の入浴剤の製剤形としては粉状、錠剤型、顆粒状
等各種の浴場に投入し易い剤型に通常の方法によって製
剤化する。The bath additives of the present invention can be formulated into various forms such as powder, tablets, and granules that can be easily added to baths by conventional methods.
次に本発明の入浴剤の実施例をあげる。 Next, examples of the bath additives of the present invention will be given.
例1
df−α−酢酸トコフェロール0.4 g 、ポリオキ
シエチレンノニルフェニルエーテル(HLB 17.8
)0.3 g及び香料3.0 gを混合機で混合し混合
液を調整する。Example 1 0.4 g of df-α-tocopherol acetate, polyoxyethylene nonylphenyl ether (HLB 17.8
) and 3.0 g of fragrance in a mixer to prepare a mixed solution.
粉末硫酸ナトリウム95.6g、ヒドロキシプロピルメ
チルセルロース0.5g及び色素0.2gを混合機に投
入し、混合を続けながら上記混合液をスプレー添加して
粉状の製品100gを得る。95.6 g of powdered sodium sulfate, 0.5 g of hydroxypropyl methylcellulose, and 0.2 g of pigment are placed in a mixer, and while mixing is continued, the mixture is sprayed to obtain 100 g of a powdered product.
例2
dIt−α−トコフェロール0.75 g 、ポリオキ
シエチレンラウリルエーテル(HLB17.7) 0.
2 g及び香料3.5gを混合機で混合し混合液を調整
する。Example 2 dIt-α-tocopherol 0.75 g, polyoxyethylene lauryl ether (HLB 17.7) 0.
2 g and 3.5 g of fragrance are mixed in a mixer to prepare a mixed liquid.
硫酸ナトリウム30.0 g、乳糖64.35 g 、
色素0.2g及びメチルセルロース0.5 gに少量の
水を加えて混練し、押出し造粒機で径1龍のベレット状
に造粒し乾燥する。次に、これをポットミ本す−に投入
し、回転しながら上記混合液をスプレー添加して顆粒状
の製品100gを得る。Sodium sulfate 30.0 g, lactose 64.35 g,
A small amount of water is added to 0.2 g of the dye and 0.5 g of methyl cellulose, and the mixture is kneaded, granulated into pellets with a diameter of 1 mm using an extrusion granulator, and dried. Next, this is put into a pot mixer, and the above mixed liquid is sprayed while rotating to obtain 100 g of a granular product.
本発明の入浴剤は、浴場に易溶性であり、浴場に溶解後
も浴湯に泡立ち及び湯垢様の浮遊物が生じない。The bath additive of the present invention is easily soluble in a bath, and does not produce foam or scale-like suspended matter in bath water even after being dissolved in a bath.
本効果を本発明の入浴剤(実施例1.2の製品)と実施
例1と同様に製造し、実施例1のヒドロキシプロピルメ
チルセルロースの代わりに同量のカルボキシメチルセル
ロースを用いた製品(比較例1)、実施例1のヒドロキ
シプロピルメチルセルロースの代わりに同量のポリビニ
ルアルコールを用いた製品(比較品2)及び、実施例1
の製造において、ヒドロキシプロピルメチルセルロース
を除外して製造した製品(比較品3)を製造し、それぞ
れの製品を浴湯1801に10gを投入した場合の泡立
ち並びに湯垢様浮遊物の有無を観察した結果を下記表に
示す。This effect was confirmed by comparing the bath additive of the present invention (product of Example 1.2) with the product manufactured in the same manner as in Example 1 and using the same amount of carboxymethyl cellulose instead of the hydroxypropyl methyl cellulose of Example 1 (Comparative Example 1). ), a product using the same amount of polyvinyl alcohol instead of hydroxypropyl methylcellulose in Example 1 (comparative product 2), and Example 1
In the production of hydroxypropyl methyl cellulose, a product (comparative product 3) was produced, and 10 g of each product was added to bath water 1801, and the results were observed for foaming and the presence or absence of scale-like suspended matter. Shown in the table below.
表 表中−は泡立ちあるいは湯垢様浮遊物を認めなかった。table In the table, no foaming or scale-like floating matter was observed.
+は泡立ちあるいは湯垢様浮遊物を認めた。+: Foaming or scale-like floating matter was observed.
以上の如く、本発明の入浴剤は入浴時浴場に投入しても
入浴時泡立ち、湯垢様浮遊物がなく、不快感を与えるこ
とがない。更に、同人浴剤中の成分であるトコフェロー
ル又はその誘導体が溶出し、入浴時の人体の皮膚より吸
収され、トコフェロールの有する末梢血管拡張作用、血
行促進作用を体内に及ぼし手足のしびれ、冷えなどの末
梢血行障害による諸症状、熟年期の老化防止に寄与する
ものである。As described above, even when the bath additive of the present invention is poured into a bathtub during bathing, there is no foaming during bathing, there is no scale-like floating matter, and there is no discomfort. Furthermore, tocopherol or its derivatives, which are ingredients in doujin bath additives, are eluted and absorbed through the skin of the human body during bathing, exerting the peripheral vasodilation and blood circulation promoting effects of tocopherol in the body, causing symptoms such as numbness in the limbs and coldness. It contributes to the prevention of various symptoms caused by peripheral blood circulation disorder and aging in middle age.
Claims (1)
活性剤及び非イオン系のアルキルセルロース又はその誘
導体を配合してなることを特徴とする入浴剤。 2、トコフェロール誘導体が酢酸トコフェロールである
特許請求の範囲第1項記載の入浴剤。 3、非イオン系のアルキルセルロース又はその誘導体が
メチルセルロース又はその誘導体である特許請求の範囲
第1項記載の入浴剤。[Scope of Claims] 1. A bath additive comprising tocopherol or a derivative thereof, a nonionic surfactant, and a nonionic alkyl cellulose or a derivative thereof. 2. The bath additive according to claim 1, wherein the tocopherol derivative is tocopherol acetate. 3. The bath additive according to claim 1, wherein the nonionic alkylcellulose or its derivative is methylcellulose or its derivative.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11953085A JPS61277609A (en) | 1985-06-01 | 1985-06-01 | Bathing agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11953085A JPS61277609A (en) | 1985-06-01 | 1985-06-01 | Bathing agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61277609A true JPS61277609A (en) | 1986-12-08 |
| JPS632934B2 JPS632934B2 (en) | 1988-01-21 |
Family
ID=14763562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11953085A Granted JPS61277609A (en) | 1985-06-01 | 1985-06-01 | Bathing agent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61277609A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0374322A (en) * | 1989-08-14 | 1991-03-28 | Osamu Yoshimura | Bathing agent containing cow's milk and production thereof |
| KR20030030867A (en) * | 2001-10-11 | 2003-04-18 | 에스에스 세야쿠 가부시키 가이샤 | Blodod circulation improving preparation |
-
1985
- 1985-06-01 JP JP11953085A patent/JPS61277609A/en active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0374322A (en) * | 1989-08-14 | 1991-03-28 | Osamu Yoshimura | Bathing agent containing cow's milk and production thereof |
| KR20030030867A (en) * | 2001-10-11 | 2003-04-18 | 에스에스 세야쿠 가부시키 가이샤 | Blodod circulation improving preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS632934B2 (en) | 1988-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS63225312A (en) | Transparent or semitransparent jelly-like cosmetic | |
| JP2000229841A (en) | Mixed type bath preparation | |
| JPS6038310A (en) | Pearl agent composition | |
| TW313525B (en) | ||
| JPH0439444B2 (en) | ||
| JP3480953B2 (en) | External preparation for skin | |
| US5602178A (en) | Bath products containing menthyl lactate | |
| JPH0751491B2 (en) | Emulsified cosmetics containing crude drugs | |
| JPS6154767B2 (en) | ||
| EP0062352B1 (en) | Soap composition | |
| US4692261A (en) | Skin bleaching detergent bar | |
| JPS61277609A (en) | Bathing agent | |
| JP2811711B2 (en) | Sharp-containing bath composition | |
| US4547307A (en) | Cake of soap with deodorizing action | |
| JP2007261947A (en) | Scrubbing agent composition and skin cosmetic comprising the same | |
| JPS6226214A (en) | Solid bath composition slowly soluble in hot water | |
| JP2638088B2 (en) | Bath additive | |
| JPH0334919A (en) | Bathing agent | |
| JP2533763B2 (en) | Bath salts containing film-like components | |
| US4142985A (en) | Method of formulating a germicidal soap | |
| JP2002205912A (en) | Skin care preparation | |
| JPS5973508A (en) | Emulsion cosmetic containing stably compounded vitamin c | |
| JPH069370A (en) | Bathing agent composition | |
| JP2909759B2 (en) | Transparent cosmetics | |
| JPH03264519A (en) | Powdery bath agent |